marginally significantP = 0.052
Conversely, VCDR was significantly lower in APACG patients in the Training ( P = 0.006) and Biomarker Validation sets ( P = 0.048), with a marginally significant trend in the Independent Validation set ( P = 0.052).
Conversely, VCDR was significantly lower in APACG patients in the Training ( P = 0.006) and Biomarker Validation sets ( P = 0.048), with a marginally significant trend in the Independent Validation set ( P = 0.052).